Surface antibodies-modification of apoferritin with encapsulated doxorubicin favorably influences the formation of protein corona
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F16%3A00092047" target="_blank" >RIV/62156489:43210/16:00092047 - isvavai.cz</a>
Alternative codes found
RIV/00216305:26620/16:PU122865
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Surface antibodies-modification of apoferritin with encapsulated doxorubicin favorably influences the formation of protein corona
Original language description
Nano-sized carriers can encapsulate anticancer drugs and deliver them to the tumor tissue. Upon entering the blood stream, many nanocarriers get covered by protein corona, hampering their entry to target cells. Thus, we aimed to study the protein corona formation around bare and Abs-modified apoferritin bearing doxorubicin.
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
CE - Biochemistry
OECD FORD branch
—
Result continuities
Project
<a href="/en/project/GA14-18344S" target="_blank" >GA14-18344S: Development of nanoparticle-based cytostatics and enzymes for enhanced chemotherapy of human neuroblastomas and study of mechanisms of their action</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů